Biologics in COPD: Why, when and who

Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients. Send us Fan MailClaim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.comFollow us on:Instagram @pulmapps Twitter@pulmapp Facebook @association of pulmonary advance practice providers.